Literature DB >> 32646279

"When You're Getting High… You Just Don't Want to Be Around Anybody." A Qualitative Exploration of Reasons for Injecting Alone: Perspectives from Young People Who Inject Drugs.

Abigail K Winiker1, Karin E Tobin1, Rachel E Gicquelais2, Jill Owczarzak1, Carl Latkin1.   

Abstract

BACKGROUND: Rates of death from opioid overdose continue to rise in the United States. One harm reduction strategy designed to reduce fatal overdose risk among people who inject drugs (PWID) is an advisory to not use drugs alone. However, the feasibility and acceptability of this message have not been evaluated.
Objectives: This paper explores the drug use practices of young PWID related to injecting alone and reasons for doing so.
Methods: From 2015 to 2016, 23 in-depth interviews were completed in Baltimore, Maryland with young PWID. Participants were recruited through street/venue-based outreach and word of mouth. Inclusion criteria were 1) age 18-30 and 2) self-report injection drug use in past 6 months. Participants were asked about drug use history, overdose knowledge/experiences, and injection-related practices including when, where, and with whom drugs were injected.
Results: Injecting drugs alone was common among members of this sample. Reasons for injecting alone included 1) the desire to alleviate withdrawal symptoms, 2) feelings of shame regarding one's drug use, 3) lack of knowledge about Good Samaritan Laws, 4) financial circumstances, and 5) a lack of trusted peers with whom to inject, often due to disrupted social networks. Conclusions: Young PWID inject alone for a variety of reasons, putting them at increased risk of fatal overdose. These findings demonstrate that "don't use alone" messages may not be sufficient given the complex realities of PWID's injection practices. Harm reduction programs employing such messaging should also offer alternative options for overdose prevention/risk reduction for those who do inject alone.

Entities:  

Keywords:  PWID; Social networks; drug stigma; fentanyl; opiates; overdose

Mesh:

Substances:

Year:  2020        PMID: 32646279      PMCID: PMC7556706          DOI: 10.1080/10826084.2020.1790008

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  29 in total

1.  High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users.

Authors:  David Frank; Pedro Mateu-Gelabert; Honoria Guarino; Alex Bennett; Travis Wendel; Lauren Jessell; Anastasia Teper
Journal:  Int J Drug Policy       Date:  2014-07-31

Review 2.  Racial/ethnic disparities in injection drug use in large US metropolitan areas.

Authors:  Hannah Cooper; Samuel R Friedman; Barbara Tempalski; Risa Friedman; Marie Keem
Journal:  Ann Epidemiol       Date:  2005-05       Impact factor: 3.797

3.  Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.

Authors:  Brandon D L Marshall; M-J Milloy; Evan Wood; Julio S G Montaner; Thomas Kerr
Journal:  Lancet       Date:  2011-04-15       Impact factor: 79.321

4.  HIV prevention among drug users: outcome of a network-oriented peer outreach intervention.

Authors:  Carl A Latkin; Susan Sherman; Amy Knowlton
Journal:  Health Psychol       Date:  2003-07       Impact factor: 4.267

5.  The influence of a peer-based HIV prevention intervention on conversation about HIV prevention among people who inject drugs in Baltimore, Maryland.

Authors:  Aleksandra Mihailovic; Karin Tobin; Carl Latkin
Journal:  AIDS Behav       Date:  2015-10

6.  The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland.

Authors:  Karin Elizabeth Tobin; Satoko Janet Kuramoto; Melissa Ann Davey-Rothwell; Carl Asher Latkin
Journal:  Addiction       Date:  2010-11-04       Impact factor: 6.526

Review 7.  Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.

Authors:  Mary Clare Kennedy; Mohammad Karamouzian; Thomas Kerr
Journal:  Curr HIV/AIDS Rep       Date:  2017-10       Impact factor: 5.071

8.  Gender differences in the initiation of injection drug use among young adults.

Authors:  M C Doherty; R S Garfein; E Monterroso; C Latkin; D Vlahov
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

9.  'It's more about the heroin': injection drug users' response to an overdose warning campaign in a Canadian setting.

Authors:  Thomas Kerr; Will Small; Elaine Hyshka; Lisa Maher; Kate Shannon
Journal:  Addiction       Date:  2013-03-28       Impact factor: 6.526

Review 10.  Historical Review: Opiate Addiction and Opioid Receptors.

Authors:  Shaocheng Wang
Journal:  Cell Transplant       Date:  2018-11-13       Impact factor: 4.064

View more
  3 in total

1.  Women's multiple uses of an overdose prevention technology to mitigate risks and harms within a supportive housing environment: a qualitative study.

Authors:  Geoff Bardwell; Taylor Fleming; Ryan McNeil; Jade Boyd
Journal:  BMC Womens Health       Date:  2021-02-02       Impact factor: 2.809

2.  Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.

Authors:  Andrew Ivsins; Laura MacKinnon; Jeanette M Bowles; Amanda Slaunwhite; Geoff Bardwell
Journal:  J Urban Health       Date:  2022-08-31       Impact factor: 5.801

3.  Anhedonia and Substance Use Disorders by Type, Severity, and With Mental Health Disorders.

Authors:  Samuel W Stull; Jeremiah W Bertz; David H Epstein; Bethany C Bray; Stephanie T Lanza
Journal:  J Addict Med       Date:  2022 May-Jun 01       Impact factor: 4.647

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.